Skip to the page

Data / Form D filings / Onyx Bio, Inc.

Onyx Bio, Inc.: Form D filings

Onyx Bio, Inc., a technology company in Berkeley, CA, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on February 26, 2026, reports $8 million sold of a $8 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
626 BANCROFT WAY SUITE A, Berkeley, CA, 94710
Phone
(415) 617-5959
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1915234

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 26, 2026New notice$7,999,999$7,999,9993Feb 13, 2026sec.gov
Mar 22, 2022New notice$5,499,991$5,326,957$173,03415Jan 28, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roger ChenExecutive Officer, Director
Amit LakhaniDirector

Other technology companies in California that filed recently

Every Form D from the week of Feb 23, 2026 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Onyx Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.